The FDA and Nipro Medical Corporation have notified healthcare professionals of a voluntary nationwide recall of all GlucoPro insulin syringes because they may have needles that detach from the ...
Dublin, July 28, 2022 (GLOBE NEWSWIRE) -- The "Global Syringes Market, By Type (General, Specialized {Insulin, Allergy, Tuberculin, Others}, Smart {Auto-Disable, Active Safety, Passive Safety}) By ...
Japanese medical equipment manufacturer Nipro Corporation recently unveiled the company's innovative disposable syringes, a timely solution that can stretch the Covid-19 vaccine dosage amid an ...
The global prefilled syringes market is forecasted to grow from USD 8.65 billion in 2026 to USD 14.53 billion by 2031, at a CAGR of 10.9%. Key growth drivers include the rising prevalence of chronic ...
WASHINGTON (Reuters) - Japanese company Nipro Corp has recalled 2 million needles distributed in the United States that are used for withdrawing blood, injecting medicine and accessing ports under ...
The US Food and Drug Administration (FDA) on Tuesday added Nipro’s Thailand site to a list of companies barred from shipping supplies of medical devices to the US because of a lack of quality. In this ...
Dublin, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Insulin Syringes Market 2022-2026" report has been added to ResearchAndMarkets.com's offering. The global Insulin Syringes Market is on the cusp ...
The “Syringes Market Analyzing Market ” Status, Trends, and Russia-Ukraine Impact Report for 2023, supplemented by the Russia-Ukraine Outbreak Impact research report from Report Ocean, provides a ...